BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased Rockwell Medical, Inc. (“Rockwell” or the “Company”) (NASDAQ: RMTI) securities between March 16, 2018 and June 26, 2018, inclusive (the “Class Period”). Rockwell investors have until September 25, 2018 to file a lead plaintiff motion.
Investors that suffered losses on their Rockwell investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to email@example.com.
The Complaint filed in this class period alleges that the Company made false and misleading statements to the market. Specifically, the complaint alleges that Rockwell Medical had knowledge that the Centers for Medicare and Medicaid Services would not pursue the Company's plan for reimbursement for Triferic; the Company's estimated reserves on form 10-Q for the quarter ending March 31, 2018, were misstated; the Company suffered from material weakness in controls for financial reporting; and that Robert L. Chioini, Rockwell's former Chief Executive Officer, failed to inform the Company's auditors, corporate counsel, and independent board members with important information about Triferic.
If you purchased shares of Rockwell during the Class Period, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to firstname.lastname@example.org, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.